Summary
Healthy male subjects orally received the diuretic thiabutazide (15 mg/day) over 3 days. Thiabutazide caused a considerable loss in sodium and fluid and thereby induced a marked secondary hyperaldosteronism. On the third day of thiabutazide treatment one half of the subjects additionally received 5 mg/kg micronized canrenone. During the experiment a moderate dietary sodium restriction and a constant fluid intake were prescribed.
Canrenone caused a significant decrease in aldosterone excretion in thiabutazide-induced hyperaldosteronism. The plasma aldosterone concentration was highly significantly reduced over more than 12 hrs after the administration of canrenone, although a marked increase in sodium and fluid excretion occurred.
It is concluded that the spirolactone canrenone is not only a competitive antagonist of aldosterone in the kidney but obviously also an inhibitor of aldosterone synthesis in man.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Erbler, H.: Stimulation of aldosterone production in vitro and its inhibition by spironolactone. Naunyn-Schmiedeberg's Arch. Pharmacol. 273, 366–375 (1972)
Erbler, H.: On the mechanism of the inhibitory action of the spirolactone SC 9376 (Aldadiene) on the production of corticosteroids in rat adrenals in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 277, 139–149 (1973)
Gochman, N., Gantt, C. L.: A fluorimetric method for the determination of a major spironolactone (aldactone) metabolite in human plasma. J. Pharmacol. exp. Ther. 135, 312 (1962)
Karim, A., Brown, E. A.: Isolation and identification of novel sulfur-containing metabolites of spironolactone (aldactone). Steroids 20, 41–62 (1972)
Sadée, M., Dagcioglu, M., Schröder, R.: Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans. J. Pharmacol. exp. Ther. 185, 686–695 (1973)
Wagner, H., Weist, F., Zicha, L.: Aldadien und andere Metaboliten im Blut und Harn nach rectaler Application von Spironolacton und intravenöser Injektion von Aldadien-Kalium. Azneimittel-Forsch. 17, 415–419 (1967)
Zicha, L., Weist, F., Scheiffarth, Schmid, E.: Dünnschichtchromatographische Untersuchung des 3′-(3-oxo-7α-acetylthio-17β-hydroxy-4-androsten-17α-yl)propionsäure-γ-lactons und seiner Metaboliten beim Menschen. Arzneimittel-Forsch. 14, 699–705 (1964)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Erbler, H.C. Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man. Naunyn-Schmiedeberg's Arch. Pharmacol. 285, 395–401 (1974). https://doi.org/10.1007/BF00501467
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501467